Activision says people spent more time playing Call of Duty in the second quarter than they did in all of 2019

San Francisco based Lyft says revenue more than doubled in latest period.

In the second quarter, Match's profit was 46 cents a share, trailing the analyst consensus.

Drugmaker focusing on non-small-cell lung cancer drug launch in second half of year.

Under Armour, ZoomInfo, Translate Bio, Outlook Therapeutics and Arcturus Therapeutics are five top gainers for Tuesday.

Stocks end higher as solid earnings reports outweigh jitters about the spread of COVID-19's delta variant and China's clampdown on its gaming and technology sectors

Clorox had a rough second quarter and Jim Cramer says big changes are needed at the consumer-products company.

SpaceX wins a round in a case involving property being used to support a rocket launch facility in Texas, a media report says.

FaZe formed a partnership with McDonald's, 'anchored by a series of dynamic content activations centered around diversity and inclusion.'

Under Armour stock is rising after the company reported better-than-expected earnings.